Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis

Background Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in multiple endocrine organs, caused by variants in the MEN1 gene. This study analyzed the clinical and genetic features of MEN1 in a Korean cohort, identifying prevalent manifestations an...

Full description

Saved in:
Bibliographic Details
Main Authors: Boram Kim, Seung Hun Lee, Chang Ho Ahn, Han Na Jang, Sung Im Cho, Jee-Soo Lee, Yu-Mi Lee, Su-Jin Kim, Tae-Yon Sung, Kyu Eun Lee, Woochang Lee, Jung-Min Koh, Moon-Woo Seong, Jung Hee Kim
Format: Article
Language:English
Published: Korean Endocrine Society 2024-12-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2024-2008.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561206723182592
author Boram Kim
Seung Hun Lee
Chang Ho Ahn
Han Na Jang
Sung Im Cho
Jee-Soo Lee
Yu-Mi Lee
Su-Jin Kim
Tae-Yon Sung
Kyu Eun Lee
Woochang Lee
Jung-Min Koh
Moon-Woo Seong
Jung Hee Kim
author_facet Boram Kim
Seung Hun Lee
Chang Ho Ahn
Han Na Jang
Sung Im Cho
Jee-Soo Lee
Yu-Mi Lee
Su-Jin Kim
Tae-Yon Sung
Kyu Eun Lee
Woochang Lee
Jung-Min Koh
Moon-Woo Seong
Jung Hee Kim
author_sort Boram Kim
collection DOAJ
description Background Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in multiple endocrine organs, caused by variants in the MEN1 gene. This study analyzed the clinical and genetic features of MEN1 in a Korean cohort, identifying prevalent manifestations and genetic variants, including novel variants. Methods This multicenter retrospective study reviewed the medical records of 117 MEN1 patients treated at three tertiary centers in Korea between January 2012 and September 2022. Patient demographics, tumor manifestations, outcomes, and MEN1 genetic testing results were collected. Variants were classified using American College of Medical Genetics and Genomics (ACMG) and French Oncogenetics Network of Neuroendocrine Tumors propositions (TENGEN) guidelines. Results A total of 117 patients were enrolled, including 55 familial cases, with a mean age at diagnosis of 37.4±15.3 years. Primary hyperparathyroidism was identified as the most common presentation (84.6%). The prevalence of gastroenteropancreatic neuroendocrine tumor and pituitary neuroendocrine tumor (PitNET) was 77.8% (n=91) and 56.4% (n=66), respectively. Genetic testing revealed 61 distinct MEN1 variants in 101 patients, with 18 being novel. Four variants were reclassified according to the TENGEN guidelines. Patients with truncating variants (n=72) exhibited a higher prevalence of PitNETs compared to those with non-truncating variants (n=25) (59.7% vs. 36.0%, P=0.040). Conclusion The association between truncating variants and an increased prevalence of PitNETs in MEN1 underscores the importance of genetic characterization in guiding the clinical management of this disease. Our study sheds light on the clinical and genetic characteristics of MEN1 among the Korean population.
format Article
id doaj-art-ad43169559dc4861a1f5f7ca6ee23712
institution Kabale University
issn 2093-596X
2093-5978
language English
publishDate 2024-12-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj-art-ad43169559dc4861a1f5f7ca6ee237122025-01-03T05:15:26ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782024-12-0139695696410.3803/EnM.2024.20082550Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective AnalysisBoram Kim0Seung Hun Lee1Chang Ho Ahn2Han Na Jang3Sung Im Cho4Jee-Soo Lee5Yu-Mi Lee6Su-Jin Kim7Tae-Yon Sung8Kyu Eun Lee9Woochang Lee10Jung-Min Koh11Moon-Woo Seong12Jung Hee Kim13 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, KoreaBackground Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in multiple endocrine organs, caused by variants in the MEN1 gene. This study analyzed the clinical and genetic features of MEN1 in a Korean cohort, identifying prevalent manifestations and genetic variants, including novel variants. Methods This multicenter retrospective study reviewed the medical records of 117 MEN1 patients treated at three tertiary centers in Korea between January 2012 and September 2022. Patient demographics, tumor manifestations, outcomes, and MEN1 genetic testing results were collected. Variants were classified using American College of Medical Genetics and Genomics (ACMG) and French Oncogenetics Network of Neuroendocrine Tumors propositions (TENGEN) guidelines. Results A total of 117 patients were enrolled, including 55 familial cases, with a mean age at diagnosis of 37.4±15.3 years. Primary hyperparathyroidism was identified as the most common presentation (84.6%). The prevalence of gastroenteropancreatic neuroendocrine tumor and pituitary neuroendocrine tumor (PitNET) was 77.8% (n=91) and 56.4% (n=66), respectively. Genetic testing revealed 61 distinct MEN1 variants in 101 patients, with 18 being novel. Four variants were reclassified according to the TENGEN guidelines. Patients with truncating variants (n=72) exhibited a higher prevalence of PitNETs compared to those with non-truncating variants (n=25) (59.7% vs. 36.0%, P=0.040). Conclusion The association between truncating variants and an increased prevalence of PitNETs in MEN1 underscores the importance of genetic characterization in guiding the clinical management of this disease. Our study sheds light on the clinical and genetic characteristics of MEN1 among the Korean population.http://www.e-enm.org/upload/pdf/enm-2024-2008.pdfmultiple endocrine neoplasiamultiple endocrine neoplasia type 1genotypephenotypevariantmulticenterkorea
spellingShingle Boram Kim
Seung Hun Lee
Chang Ho Ahn
Han Na Jang
Sung Im Cho
Jee-Soo Lee
Yu-Mi Lee
Su-Jin Kim
Tae-Yon Sung
Kyu Eun Lee
Woochang Lee
Jung-Min Koh
Moon-Woo Seong
Jung Hee Kim
Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
Endocrinology and Metabolism
multiple endocrine neoplasia
multiple endocrine neoplasia type 1
genotype
phenotype
variant
multicenter
korea
title Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
title_full Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
title_fullStr Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
title_full_unstemmed Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
title_short Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
title_sort genetic landscape and clinical manifestations of multiple endocrine neoplasia type 1 in a korean cohort a multicenter retrospective analysis
topic multiple endocrine neoplasia
multiple endocrine neoplasia type 1
genotype
phenotype
variant
multicenter
korea
url http://www.e-enm.org/upload/pdf/enm-2024-2008.pdf
work_keys_str_mv AT boramkim geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT seunghunlee geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT changhoahn geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT hannajang geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT sungimcho geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT jeesoolee geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT yumilee geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT sujinkim geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT taeyonsung geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT kyueunlee geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT woochanglee geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT jungminkoh geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT moonwooseong geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis
AT jungheekim geneticlandscapeandclinicalmanifestationsofmultipleendocrineneoplasiatype1inakoreancohortamulticenterretrospectiveanalysis